DIM
EVH icon

DC Investments Management’s Evolent Health EVH Stock Holding History

DC Investments Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-40,600
Closed -$343K – 64
2025
Q3 		$343K Hold
40,600
– – 0.14% 82
2025
Q2 		$457K Hold
40,600
– – 0.19% 79
2025
Q1 		$384K Buy
+40,600
New +$410K 0.2% 94
2020
Q3 		– Sell
-1,164,666
Closed -$8.29M – 142
2020
Q2 		$8.29M Buy
1,164,666
+159,366
+16% +$1.07M 3.05% 5
2020
Q1 		$5.46M Buy
1,005,300
+372,687
+59% +$3.33M 4.43% 1
2019
Q4 		$5.72M Buy
632,613
+166,896
+36% +$1.36M 4.38% 1
2019
Q3 		$3.35M Buy
465,717
+284,119
+156% +$2.04M 1.94% 4
2019
Q2 		$1.44M Buy
+181,598
New +$2.15M 0.81% 5

Other funds holding EVH

CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

DC Investments Management's EVH Position: Q4 2025 in Review

DC Investments Management sold out of Evolent Health (EVH) in Q4 2025, closing a stake of 40,600 shares — an estimated $343K sold.

DC Investments Management first reported a position in EVH in Q2 2019 and held it in 8 quarters. The position peaked at $8.29M in Q2 2020. 215 funds tracked by Wall St. Rank hold EVH as of Q4 2025.

  • DC Investments Management reported no remaining Evolent Health position as of Q4 2025 after selling out during the quarter.
  • DC Investments Management sold 40,600 Evolent Health shares in Q4 2025, an estimated $343K.
  • DC Investments Management first reported a position in Evolent Health in Q2 2019 and held it in 8 quarters.
  • DC Investments Management's Evolent Health position peaked at $8.29M in Q2 2020.
  • 215 funds tracked by Wall St. Rank held Evolent Health as of Q4 2025.

Based on DC Investments Management's 13F filing for Q4 2025, filed 13 Feb 2026.